USP21 and hepatocellular carcinoma: Due to the reason that USP21 expression may be correlated with the OS of HCC patients, then, drug sensitivity test between USP21 and six common molecular drugs (Sorafenib, Axitinib, Dasatinib, Erlotinib, Imatinib and Nilotinib) were performed (Fig. 9I).